Generics and biosimilars warrant separate strategies and approaches. The Centre needs to ensure tighter controls before approval and periodic quality checks to ensure every batch shows consistent quality
#HealthMatters #India #Shortcuts #Biosimilars #ConfusingAffordability #EfficacyBadIdea
https://www.news18.com/india/health-matters-india-shortcuts-making-biosimilars-confusing-affordability-efficacy-bad-idea-8351533.html

All approved #biosimilars in the 🇪🇺 are interchangeable 💊.

But it is important that #patients and healthcare professionals carefully read the product information before interchanging a biosimilar treatment.

https://www.ema.europa.eu/en/human-regulatory/overview/biosimilar-medicines-overview

Learn more in this video ⬇️

🐦🔗: https://n.respublicae.eu/EMA_News/status/1654381412362117121

FDA rejects Teva’s high-potency biosimilar of Humira again — After a record run, fewer biotechs are going public— Sarepta shares drop as report says FDA almost rejected under-review gene therapy -- See more on our front page news http://bit.ly/w28kSd #tevapharma #fda #humira #abbvie #biosimilars #ipos #genetherapy #sarepta #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Two things that should drive #DrugPrices down – #PBMs and #biosimilars – aren't really working that way. Could it be that our health systems are tuned for profiteering?https://conscienhealth.org/2023/04/biosimilars-and-pbms-the-jokes-on-us/

Making an informed decision: the key questions to ask when considering a biosimilar

#biosimilars #patientcare #medicationoptions #costeffectiveness

Tim de Gavre is vice president and chief commercial officer, Sandoz.

https://youtube.com/shorts/rObtgyEhcIs

Listen here: https://kevinmd.com/podcast

The power of biosimilars: the benefits of FDA-approved biologics

#biosimilars #FDAapproval #patientcare #medicationoptions

Tim de Gavre is vice president and chief commercial officer, Sandoz.

https://youtube.com/shorts/ymuhXcxsp9c

Listen here: https://kevinmd.com/podcast

Sandoz files biosimilar of Amgen osteoporosis drug in US — Led by Merck, Vertex and Lilly, pharma's share prices largely climbed in '22 despite economic angst —Eisai gives first glimpse into Alzheimer’s drug launch -- See more on our front page news http://bit.ly/w28kSd #sandoz #biosimilars #novartis #amgen #osteoporosis #pharmastocks #merck #eisai #elililly #alzheimers #druglaunch #pharma #pharmanews #biopharma #biotech #cafepharma

Amgen, navigating 'industry headwinds,' puts 300 commercial jobs on chopping block — The end of the Humira era — Biotech pipeline hosts 163 potential meds for mental illness, with depression dominating -- See more on our front page news http://bit.ly/w28kSd #amgen #layoffs #humira #biosimilars #abbvie #biotech #pipeline #mentalhealth #mentalillness #depression #pharma #pharmanews #biotechnology #biopharma #cafepharma

Interesting slide from @BertrandBio (attending #JPM23 I aussume) concerning biosimilar patent stretch with Entyvia.

How Big Pharma gets 3-5y of add. peak sales for almost nothing in the US, in 1 slide: #SystemFAIL

https://twitter.com/BertrandBio/status/1612766357724057601

#patents #biosimilars #pharmaceuticals

BioNTech buys UK AI start-up InstaDeep in £562mn deal — JPM23: Gilead, Takeda, Pfizer, Moderna and more —The Big Three PBMs’ 2023 formulary exclusions: observations on insulin, Humira, and biosimilars -- See more on our front page news http://bit.ly/w28kSd #biontech #artificialintelligence #ai #mergersandacquisitions #jpm23 #jpm2023 #pfizer #moderna #takeda #gileadsciences #formulary #humira #pbms #biosimilars #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

#Biologics will be replaced by #biosimilars in #Ontario. #Remicade #IBD #Crohns #UC 'The provincial government said certain drugs covered by the ODB will be switched to Health Canada-approved “biosimilar” versions of the medications' https://www.ctvnews.ca/canada/here-are-some-of-the-new-laws-and-rules-coming-into-effect-in-canada-in-2023-1.6211918

Humira #biosimilars set the stage for long-awaited 2023 US launches - Pharmaceutical Technology

https://www.pharmaceutical-technology.com/features/humira-biosimilars-set-the-stage-for-long-awaited-2023-us-launches/ “There are seven FDA-approved Humira biosimilars, of which Amgen’s Amjevita will be launched in January. Others are made by big pharma giants like Boehringer Ingelheim, Novartis, or Pfizer, which has raised the expectations for a competitive market. “ #pharma

Humira #biosimilars set the stage for long-awaited 2023 US launches - Pharmaceutical Technology

https://www.pharmaceutical-technology.com/features/humira-biosimilars-set-the-stage-for-long-awaited-2023-us-launches/ “There are seven FDA-approved Humira biosimilars, of which Amgen’s Amjevita will be launched in January. Others are made by big pharma giants like Boehringer Ingelheim, Novartis, or Pfizer, which has raised the expectations for a competitive market. “ #pharma

RT @MondayNightIBD
#GITwitter With many ADAL #Biosimilars becoming available soon

@GI_PharmD reviews what we need to know & what to watch for our #IBD pts

🗳️#IBDPolls👇🏽

🆓#CME👉🏼http://bit.ly/3k6SHG8

Support by edu grants @abbvie @ferring @JanssenUS @TakedaPharma

📌Where r u in your career?

RT @MondayNightIBD
#GITwitter With many ADAL #Biosimilars becoming available soon

@GI_PharmD reviews what we need to know & what to watch for our #IBD pts

🗳️#IBDPolls👇🏽

🆓#CME👉🏼http://bit.ly/3k6SHG8

Support by edu grants @abbvie @ferring @JanssenUS @TakedaPharma

📌Where r u in your career?

RT @GI_PharmD
@DCharabaty @MondayNightIBD A1b. We have #biosimilars for IFX. #Adalimumab (ADAL) biosimilars are expected in 2023. Biosimilars could create savings (up to $124.5 billion 💰) for the healthcare system, with ADAL biosimilar being the biggest contributor.

RT @DCharabaty
@GI_PharmD @MondayNightIBD Q2. @GI_PharmD How many #Biosimilars to ADAL are expected to be launched in 2023 ? What Biosimilar “names” should we start becoming familiar with?

RT @DCharabaty
@GI_PharmD @MondayNightIBD Q5. Lots of subtleties we need to become familiar with Re: ADA biosimilars @GI_PharmD !

How about methods of delivery/ injection ? Do we expect the same RP pen? Are the #Biosimilars citrate & latex free ?

#GITwitter With many ADAL #Biosimilars becoming available soon

@GI_PharmD reviews what we need to know & what to watch for our #IBD pts

🗳️#IBDPolls👇🏽

🆓#CME👉🏼http://bit.ly/3k6SHG8

Support by edu grants @abbvie @ferring @JanssenUS @TakedaPharma

📌Where r u in your career?